Maeve Waldron-Lynch

Maeve Waldron-Lynch is an accomplished executive in the pharmaceutical industry with extensive experience in clinical development. Currently serving as Senior Vice President and Head of Clinical Development at Tango Therapeutics, Maeve has held significant leadership roles, including Global Clinical Program Head for Tafasitamab and Senior Global Program Medical Director at MorphoSys. Previous positions include Clinical Development Medical Director at Novartis, Senior Clinical Director for PD Oncology at Roche, and Associate Director of Medical Science in Oncology at Mundipharma. Throughout these roles, Maeve has demonstrated expertise in oncology and clinical program management.